Neovacs
Biotech firm developing immunotherapies and investing in BioTech and MedTech.
ALNEV | Euronext Growth
Overview
Corporate Details
- ISIN(s):
- FR0004032746 (+4 more)
- LEI:
- 9695001J9GMM5XYK6482
- Country:
- France
- Address:
- 14 RUE DE LA REPUBLIQUE, 92150 SURESNES
- Website:
- https://www.neovacs.com/en/
Description
Neovacs is a biotechnology company with two main activities: research and development, and investment. The company's R&D focuses on its proprietary Kinoid technology platform, an active immunotherapy approach for treating autoimmune diseases and allergies. This technology develops therapeutic vaccines designed to stimulate the patient's immune system to regulate the overproduction of harmful cytokines. Key indications for its Kinoid products include lupus. In addition to its internal development, Neovacs invests in high-potential BioTech and MedTech companies, leveraging its experienced team to evaluate and support innovative products and medical devices.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2023-02-07 18:00 |
Information relative au nombre total de droits de vote et d'actions composant l…
|
French | 152.6 KB | ||
| 2023-01-24 08:30 |
Néovacs pourrait devenir associé commandité de Pharnext
|
French | 206.6 KB | ||
| 2023-01-19 08:30 |
Signature d'une convention encadrant le financement de Pharnext par Néovacs
|
French | 152.3 KB | ||
| 2023-01-10 18:00 |
Levée de fonds de 1 MEUR
|
French | 163.0 KB | ||
| 2023-01-04 18:00 |
INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D'ACTIONS COMPOSANT L…
|
French | 179.4 KB | ||
| 2022-12-28 20:00 |
PHARNEXT RENFORCE SES LIENS AVEC NÉOVACS POUR ASSURER LES PROCHAINES ÉTAPES DE …
|
French | 223.4 KB | ||
| 2022-12-19 18:00 |
RÉDUCTION DE LA VALEUR NOMINALE DE L'ACTION
|
French | 166.6 KB | ||
| 2022-12-06 19:30 |
INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D'ACTIONS COMPOSANT L…
|
French | 178.0 KB | ||
| 2022-11-09 08:00 |
NOMINATION D'HUGO BRUGIÈRE, PDG DE NÉOVACS, AU CONSEIL D'ADMINISTRATION DE PHAR…
|
French | 158.2 KB | ||
| 2022-11-08 19:00 |
INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D'ACTIONS COMPOSANT L…
|
French | 175.9 KB | ||
| 2022-10-31 19:15 |
RÉSULTATS SEMESTRIELS 2022 : ACCÉLÉRATION DE LA FEUILLE DE ROUTE STRATÉGIQUE DA…
|
French | 237.6 KB | ||
| 2022-10-31 19:00 |
LEVÉE DE FONDS DE 2 MEUR
|
French | 169.1 KB | ||
| 2022-10-31 18:45 |
AVANCÉES DU FINANCEMENT ACCORDÉ À PHARNEXT
|
French | 243.5 KB | ||
| 2022-10-12 08:00 |
DÉPÔT D'UNE NOUVELLE DEMANDE DE BREVET INTERNATIONALE SUR L'UTILISATION DE LA T…
|
French | 207.7 KB | ||
| 2022-10-04 08:00 |
NÉOVACS ACCORDE À PHARNEXT UN FINANCEMENT D'UN MONTANT NOMINAL DE 21,1 MEUR (SO…
|
French | 331.8 KB |
Automate Your Workflow. Get a real-time feed of all Neovacs filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Neovacs
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Neovacs via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
